Infecciones fúngicas en pacientes inmunosuprimidos
Fungal infections in immunosuppressed patients
Contenido principal del artículo
Descargas
Detalles del artículo
Referencias (VER)
Neofytos D, Lu K, Hatfield-Seung A, Blackford A, Marr KA, Treadway S, et al. Epidemiology outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy. Diagn Microbiol Infect Dis. 2013;75:144-9.
Soysal A. Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole. Infect Drug Resist. 2015:8 321-31.
Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopietic stem-cell transplantation. Lancet Oncol. 2014;15:e327-40.